Skip to main content

Table 1 Patient characteristics

From: Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction

Variable Total study LVGFI ≥ median LVGFI < median p-value
N = 795 n = 397 n = 398
Age (years) 62 (51 – 71) 61 (51 – 70) 63 (51 – 71) 0.40
Male sex: n (%) 603 / 795 (76 %) 283 / 397 (71 %) 320 / 398 (80 %) 0.003
Cardiovascular risk factors: n (%)     
 Current smoking 339 / 727 (47 %) 169 / 359 (47 %) 170 / 368 (46 %) 0.81
 Hypertension 540 / 792 (68 %) 256 / 394 (65 %) 284 / 398 (71 %) 0.05
 Hypercholesterolemia 304 / 787 (39 %) 152 / 391 (39 %) 152 / 396 (38 %) 0.88
 Diabetes mellitus   77 / 395 (20 %) 83 / 397 (21 %)  0.62
BMI (kg/m2) 27.3 (24.9 – 30.3) 27.7 (24.9 – 30.4) 27.7 (24.8 – 30.3) 0.48
Previous infarction: n (%) 48 / 794 (6 %) 18 / 396 (5 %) 30 / 398 (8 %) 0.08
Anterior infarction: n (%) 363 / 758 (48 %) 127 / 377 (34 %) 236 / 381 (62 %) <0.001
Times (min)     
 Symptom-onset to PCI hospital admission 180 (109 – 310) 160 (100 – 285) 190 (116 – 346) 0.005
 Door-to-balloon-time 30 (22 – 42) 30 (22 – 42) 29 (22 – 42) 0.28
Killip-class on admission: n (%)     <0.001
 1 699 / 795 (88 %) 373 / 397 (94 %) 326 / 398 (82 %)  
 2 59 / 795 (7 %) 15 / 397 (4 %) 44 / 398 (11 %)  
 3 20 / 795 (3 %) 4 / 397 (1 %) 16 / 398 (4 %)  
 4 17 / 795 (2 %) 5 / 397 (1 %) 12 / 398 (3 %)  
Number of diseased vessels: n (%)     0.18
 1 422 / 795 (53 %) 225 / 397 (57 %) 197 / 398 (50 %)  
 2 225 / 795 (28 %) 107 / 397 (27 %) 118 / 398 (30 %)  
 3 148 / 795 (19 %) 65 / 397 (16 %) 83 / 398 (21 %)  
Infarct related artery: n (%)     <0.001
 Left anterior descending 347 / 795 (44 %) 117 / 397 (30 %) 230 / 398 (58 %)  
 Left circumflex 97 / 795 (12 %) 51 / 397 (13 %) 46 / 398 (12 %)  
 Right coronary artery 344 / 795 (12 %) 227 / 397 (57 %) 117 / 398 (29 %)  
 Left main 5 / 795 (1 %) 2 / 397 (1 %) 3 / 398 (1 %)  
 Bypass graft 2 / 795 (<1 %) 0 / 397 (0 %) 2 / 398 (1 %)  
TIMI-flow before PCI: n (%)     0.001
 TIMI-flow 0 445 / 795 (56 %) 204 / 397 (51 %) 241 / 398 (61 %)  
 TIMI-flow I 104 / 795 (13 %) 46 / 397 (12 %) 58 / 398 (15 %)  
 TIMI-flow II 129 / 795 (16 %) 70 / 397 (18 %) 59 / 398 (15 %)  
 TIMI-flow III 117 / 795 (15 %) 77 / 397 (19 %) 40 / 398 (10 %)  
Stent implanted: n (%) 777 / 795 (98 %) 388 / 397 (98 %) 389 / 398 (98 %) 0.94
Thrombectomy: n (%) 190 / 795 (24 %) 88 / 397 (22 %) 102 / 398 (26 %) 0.25
TIMI-flow post PCI: n (%)     0.12
 TIMI-flow 0 12 / 794 (2 %) 4 / 397 (1 %) 8 / 397 (2 %)  
 TIMI-flow I 104 / 795 (13 %) 5 / 397 (1 %) 14 / 397 (4 %)  
 TIMI-flow II 62 / 794 (8 %) 31 / 397 (8 %) 31 / 397 (8 %)  
 TIMI-flow III 701 / 794 (88 %) 357 / 397 (90 %) 344 / 397 (87 %)  
 TIMI-risk score 3 (2 – 5) 3 (2 – 4) 4 (2 – 5) <0.001
ST-segment resolution 54 (21 – 78) 63 (28 – 81) 49 (14 – 72) 0.02
Intraaortic balloon pump: n (%) 35 / 795 (4 %) 10 / 397 (3 %) 25 / 398 (6 %) 0.01
Concomitant medications: n (%)     
 ß-blockers 759 / 793 (96 %) 376 / 396 (95 %) 383 / 397 (97 %) 0.29
 ACE-inhibitors/AT-1-antagonist 754 / 793 (95 %) 378 / 396 (96 %) 376 / 397 (95 %) 0.63
 Aspirin 795 / 795 (100 %) 397 / 397 (100 %) 398 / 398 (100 %)  
 Clopidogrel, prasugrel or both 775 / 77 % (100 %) 397 / 397 (100 %) 398 / 398 (100 %)  
 Statins 752 / 793 (95 %) 382 / 396 (97 %) 370 / 397 (93 %) 0.04
 Aldosterone antagonist 49 / 393 (13 %) 15 / 396 (4 %) 76 / 397 (19 %) <0.001
 Abciximab 748 / 794 (94 %) 370 / 397 (93 %) 378 / 397 (95 %) 0.91
  1. Continuous data are presented as median and interquartile range
  2. LVGFI = left ventricular global function index, ACE = angiotensin-converting enzyme, AT-1 = angiotensin1, BMI = body mass index, CABG = coronary artery bypass graft, CMR = cardiovascular magnetic resonance, IQR = interquartile range, Med = Median, PCI = primary percutaneous coronary intervention, TIMI = Thrombolysis in Myocardial Infarction